As the need arises for specialty molecules to treat chronic diseases, and as new technologies become available to produce natural, synthetic and bio-synthetic APIs with better results, Noramco will adopt special purpose technology platforms.

These include, but are not limited to platforms pertaining to:

  • Custom synthesis products
  • APIs produced by bio-catalysis
  • Controlled substance building blocks and intermediates